Aspen Aerogels (NYSE:ASPN) Trading Down 4.9% After Analyst Downgrade

Aspen Aerogels, Inc. (NYSE:ASPN)’s share price fell 4.9% during trading on Friday after Canaccord Genuity Group lowered their price target on the stock from $20.00 to $15.00. Canaccord Genuity Group currently has a buy rating on the stock. Aspen Aerogels traded as low as $8.54 and last traded at $8.56. 1,276,875 shares traded hands during trading, a decline of 35% from the average session volume of 1,978,913 shares. The stock had previously closed at $9.00.

A number of other equities analysts also recently commented on ASPN. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a research report on Saturday, February 8th. Seaport Res Ptn cut shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Roth Mkm reduced their price objective on shares of Aspen Aerogels from $36.00 to $31.00 and set a “buy” rating for the company in a research report on Friday, November 8th. Craig Hallum dropped their target price on Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday. Finally, Barclays reduced their price target on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a report on Tuesday, November 12th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $26.33.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in ASPN. AlphaQuest LLC grew its position in shares of Aspen Aerogels by 54.0% in the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after purchasing an additional 3,998 shares during the period. nVerses Capital LLC grew its stake in shares of Aspen Aerogels by 45.0% during the 3rd quarter. nVerses Capital LLC now owns 5,800 shares of the construction company’s stock valued at $161,000 after buying an additional 1,800 shares during the period. KLP Kapitalforvaltning AS purchased a new position in shares of Aspen Aerogels in the 4th quarter worth $164,000. Journey Strategic Wealth LLC acquired a new position in Aspen Aerogels in the fourth quarter valued at $178,000. Finally, Ballentine Partners LLC grew its position in Aspen Aerogels by 19.2% during the fourth quarter. Ballentine Partners LLC now owns 15,914 shares of the construction company’s stock valued at $189,000 after acquiring an additional 2,565 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 5.1 %

The company has a market capitalization of $701.04 million, a PE ratio of 857.56 and a beta of 2.14. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.48 and a current ratio of 2.93. The business has a fifty day moving average price of $12.36 and a 200 day moving average price of $18.63.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 0.36% and a return on equity of 5.06%. Analysts expect that Aspen Aerogels, Inc. will post 0.12 EPS for the current fiscal year.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.